Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15280012 | 0.98 | PTGDR2 (0.87) | PTGDR2 | |
| SCHEMBL15519218 | 0.98 | PTGDR2 (0.87) | PTGDR2 | |
| SCHEMBL2215872 | 0.91 | PTGDR2 (1.00) | PTGDR2 | |
| SCHEMBL2214672 | 0.91 | PTGDR2 (1.00) | PTGDR2 | |
| SCHEMBL15518279 | 0.91 | PTGDR2 (1.00) | PTGDR2 | |
| SCHEMBL15509573 | 0.91 | PTGDR2 (0.75) | PTGDR2 | |
| SCHEMBL2213260 | 0.91 | PTGDR2 (0.75) | PTGDR2 | |
| SCHEMBL15280587 | 0.90 | PTGDR2 (0.71) | PTGDR2 | |
| Acetic Acid SCHEMBL2321469 | 0.86 | PTGDR2 (0.63) | PTGDR2 | |
| SCHEMBL22227397 | 0.85 | PTGDR2 (0.73) | PTGDR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546422-B2 | Azaindole derivatives as CRTH2 receptor antagonists | MERCK CANADA INC. (CA) | 2013-10-01 | — | — | US | disclosed |